Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Viewpoint] US Preventive Services Task Force recommendation statement regarding screening for peripheral artery disease with the ankle-brachial index: déjà vu all over again

On July 10, 2018, in the Journal of the American Medical Association, the US Preventive Services Task Force (USPSTF) published its 2018 update of the 2013 recommendation on screening for peripheral artery disease and cardiovascular disease risk assessment by measuring the ankle-brachial index (ABI).1 The conclusion is the same as in the 2013 report: “current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease and cardiovascular disease risk with the ABI in asymptomatic adults.”1 This conclusion applies to asymptomatic adults without a known diagnosis of peripheral artery disease, cardiovascular disease, or severe chronic kidney disease.

email